摘要 |
Indolylmaleimide derivatives comprising either a substituted phenyl, naphthyl, tetrahydronaphthyl, quinazolinyl, quinolyl, isoquinolyl or pyrimidinyl residue have interesting pharmaceutical properties, e.g. in the treatment and/or prevention of T-cell mediated acute or chronic inflammatory diseases or disorders, autoimmune diseases, graft rejection or cancer.
|
申请人 |
NOVARTIS AG;NOVARTIS PHARMA GMBH;ALBERT, RAINER;COOKE, NIGEL, GRAHAM;COTTENS, SYLVAIN;EHRHARDT, CLAUS;EVENOU, JEAN-PIERRE;SEDRANI, RICHARD;VON MATT, PETER;WAGNER, JUERGEN;ZENKE, GERHARD |
发明人 |
ALBERT, RAINER;COOKE, NIGEL, GRAHAM;COTTENS, SYLVAIN;EHRHARDT, CLAUS;EVENOU, JEAN-PIERRE;SEDRANI, RICHARD;VON MATT, PETER;WAGNER, JUERGEN;ZENKE, GERHARD |